|
End-of-day quote
Lima
2026-08-14
|
5-day change | 1st Jan Change | ||
| 63.67 USD | 0.00% |
|
-2.75% | +18.21% |
| 08-17 | AstraZeneca suffers another setback as it halts volrustomig lung cancer trial | RE |
| 08-16 | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
Stock exchange
Lima
BMYUS 63.67 $
0.00%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BMY | 64.63USD | +1.25% | 471M $ | ||
CBOE
| BMY | 64.65USD | +1.27% | 18.91M $ | |
Xetra
| BRM | 55.62EUR | +1.05% | 126K € | |
Deutsche Boerse AG
| BRM | 54.40EUR | -0.60% | 29.1K € | |
Borsa Italiana
| 1BMY | 55.61EUR | +0.93% | 26.64K € | |
CBOE
| 0R1F | 55.60EUR | +1.18% | 14.07K € | |
Tradegate
| BRM | 55.63EUR | -0.36% | 7.62K € | |
Mexican S.E.
| BMY * | 1,085.29MXN | -1.34% | 91.16K $ | |
London S.E.
| 0R1F | 63.85USD | +0.47% | 383.1 $ | |
Swiss Exchange
| BMY | 52.00CHF | +0.02% | 0 CHF | |
Swiss Exchange
| BMY | 64.22USD | +0.27% | 0 $ | |
Börse Stuttgart
| BRM | 55.67EUR | +0.02% | 0 € | |
Wiener Boerse
| BMYS | 55.61EUR | +0.94% | 0 € | |
Boerse Muenchen
| BRM | 55.77EUR | 0.00% | 0 € | |
Lima
| BMYUS | 63.67USD | 0.00% | 0 $ | |
CBOE
| 55.96EUR | 0.00% | 0 € | ||
| BMYB34 | 335.92BRL | +2.20% | 275K R$ | ||
| BMY | 33,500.00ARS | -1.76% | 7.34M $ | ||
Buenos Aires S.E.
| BMYD | 21.97USD | -3.85% | 65.91 $ |
Quotes 5-day view: Bristol-Myers Squibb Company
End-of-day quote Lima| 2026-08-11 | 2026-08-12 | 2026-08-13 | 2026-08-14 | 2026-08-17 | |
|---|---|---|---|---|---|
| Last | US$64.84 | US$63.67 | US$63.67 | US$63.67 | US$63.67 |
| Volume | 0 | 200 | 0 | 0 | 0 |
| Change | -0.96% | -1.80% | 0.00% | 0.00% | 0.00% |
| Opening | US$64.84 | US$63.67 | US$63.67 | US$63.67 | US$63.67 |
| High | US$64.84 | US$63.67 | US$63.67 | US$63.67 | US$63.67 |
| Low | US$64.84 | US$63.67 | US$63.67 | US$63.67 | US$63.67 |
Performance
| 1 week | -2.75% | ||
| Current month | +1.77% | ||
| 1 month | +7.30% | ||
| 3 months | +14.37% | ||
| 6 months | +20.00% | ||
| Current year | +18.21% | ||
| 1 year | +38.08% | ||
| 3 years | -12.42% | ||
| 5 years | -4.54% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
132,020,648,217
Net sales (USD)
48,194,000,000
Number of employees
32,500
Sales / Employee (USD)
1,482,892
Free-Float
69.82 %
Free-Float capitalization (USD)
131,886,398,781
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
64.26
Moving average 20 days
62.14
Moving average 50 days
58.53
Moving average 100 days
57.81
Price spread / (MMA5)
+0.93%
Price spread / (MMA20)
-2.40%
Price spread / (MMA50)
-8.07%
Price spread / (MMA100)
-9.20%
STIM
RSI 9 days
63.45
RSI 14 days
68.12
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -2.75% | +38.08% | -12.42% | 132B | ||
| +0.25% | -3.96% | +68.73% | +120.06% | 1,055B | ||
| +0.78% | +0.21% | +48.53% | +50.78% | 632B | ||
| +0.35% | +0.95% | +21.11% | +66.86% | 442B | ||
| +0.28% | -4.56% | +39.10% | +38.05% | 351B | ||
| +0.78% | -2.68% | +24.03% | +37.32% | 290B | ||
| +0.87% | -3.59% | -0.28% | +7.12% | 243B | ||
| +1.00% | +0.52% | +41.46% | +58.95% | 227B | ||
| -0.78% | -4.49% | -10.28% | -54.13% | 200B | ||
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | ||
| Average | +0.39% | -1.44% | +28.79% | +39.42% | 374.45B | |
| Weighted average by Cap. | +0.42% | -1.87% | +39.66% | +61.19% |
Historical Quotes: Bristol-Myers Squibb Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 63.67 | 63.67 | |
| 1 month | 59.34 | 65.47 | |
| Current year | 52.02 | 65.47 | |
| 1 year | 43.5 | 65.47 | |
| 3 years | 40.1 | 72.7 | |
| 5 years | 40.1 | 72.7 | |
| 10 years | 40.1 | 72.7 |
Monthly variations
Annual variations
| 2026 | +18.21% | ||
| 2025 | -9.93% | ||
| 2024 | +16.46% | ||
| 2023 | -29.37% | ||
| 2022 | +27.10% | ||
| 2021 | -8.99% | ||
| 2020 | 0.00% |
- Stock Market
- Stocks
- BMY Stock
- BMYUS Stock
- Quotes Bristol-Myers Squibb Company
Select your edition
All financial news and data tailored to specific country editions

















